All News

A group of pharmacies and pharmacy organizations urged the Centers for Medicare & Medicaid Services to formally recognize and promote medical at home pharmacy services for long-term care.

NACDS is urging the Drug Enforcement Administration to make electronic prescriptions for controlled substances mandatory.

Kroger Health will start offering its COVID-19 Test Home Collection Kit with the guidance of a telehealth consultation.

The CDC has identified the pharmacy sector as a key partner in offering its lifestyle change-based program for patients with high risk for type 2 diabetes.

A collaboration between APhA and PTCB will help provide pharmacy technician credentialing in immunization delivery.

A Johns Hopkins research team has determined that tests are more likely to result in false negatives for the COVID-19 virus if taken too early in the course of infection.

In a new guidance, the FDA provides recommendations for those developing COVID-19 vaccines to ensure safety and efficacy.

An updated list of risk factors for severe COVID-19 expands possible underlying medical conditions and removes the age threshold.

Through the print publication and a growing digital footprint, Drug Topics® provides a dynamic range of content across the pharmaceutical spectrum.

Officials with the FDA approved fenfluramine (Fintepla, Zogenix) oral solution, CIV for the treatment of seizures associated with Dravet syndrome in patients 2 years of age and older.

Demand for an affordable generic steroid soared after preliminary findings from a study showed it may be effective in reducing deaths from the coronavirus disease 2019 (COVID-19).

The MMR vaccine may demonstrate some degree of protection against septic inflammation, a symptom of COVID-19, according to a team of experts.

Results of a PLOS ONE study determined a positive relationship between COPD and smoking and mortality rates from COVID-19.

A new poll by Gallup and West Health found that a majority of Americans have expressed numerous health care system-related concerns, including rising costs of drugs, insurance premiums, and health care in response to COVID-19.

The FDA warned that the dosing cups, which were missing some graduation markings, could cause an accidental overdose.

Until social distancing measures are phased out, store owners who want to make a difference in independent pharmacy can and should leverage technology to connect with legislators virtually.

Here's a roundup of this week's coronavirus-related news.

As reopening efforts and recovery plans start to take hold, it should be recognized that community pharmacies are ideally positioned to support this national effort.

EndeavorRx (Akili Interactive), a prescription-only game-based device, is indicated for use in children ages 8 to 12 years old with primarily inattentive or combined-type ADHD who have demonstrated an attention issue.

The CDC released an updated vaccination guidance on administering routine vaccinations amid the coronavirus disease 2019 (COVID-19) pandemic.

Via a new web platform, pharmacy technicians are sharing their personal challenges during the coronavirus disease 2019 (COVID-19) pandemic.

The FDA updated its fact sheet on the co-administration of remdesivir with chloroquine phosphate or hydroxychloroquine.

Abbott’s FreeStyle Libre 2 is an integrated continuous glucose monitoring system for adults and children ages 4 and older with diabetes.

Armand Balboni, MD, PhD, chief executive officer of Appili Therapeutics, discusses the potential for favipiravir, an antiviral medication, for treating COVID-19 in certain populations.

Since the emergency use authorization was granted, new data on heart risks associated with hydroxychloroquine and chloroquine have been revealed.

Officials with the FDA have approved dolutegravir (Tivicay PD, ViiV Healthcare) dispersible tablets for oral suspension for children who are at least 4 weeks of age and weigh at least 3 kg.

In part 2 of our interview, Armand Balboni, MD, PhD, chief executive officer of Appili Therapeutics, discusses the potential for favipiravir, an antiviral medication, for treating COVID-19 in certain populations.

An analysis focused on patients with type 2 diabetes in rural regions, where accessibility to physicians is often limited.